Literature DB >> 19376553

The impact of visceral adipose tissue and high-molecular weight adiponectin on cardio-ankle vascular index in asymptomatic Japanese subjects.

Norihiko Ohashi1, Chikako Ito, Rumi Fujikawa, Hideya Yamamoto, Yasuki Kihara, Nobuoki Kohno.   

Abstract

Few studies addressed the relation of visceral adiposity and high-molecular weight (HMW) adiponectin to arterial stiffness. We investigated the impact of visceral adipose tissue (VAT) and HMW adiponectin on cardio-ankle vascular index (CAVI) in asymptomatic Japanese subjects. We studied 487 consecutive subjects (271 men and 216 women) who underwent general health examination between October 2005 and May 2008. The abdominal, visceral, and subcutaneous adipose tissue areas were determined by low-dose x-ray computed tomography. Serum levels of total and HMW adiponectin were measured using the enzyme-linked immunosorbent assay system based on a monoclonal antibody to humans. Cardio-ankle vascular index was positively correlated with VAT area and negatively correlated with HMW adiponectin levels. We also found the positive association of the number of metabolic syndrome components with CAVI in both sexes. A stepwise multiple regression analysis revealed that age, VAT area, serum HMW adiponectin levels, and homeostasis model assessment of insulin resistance were independent determinants of CAVI. Receiver operating characteristic analyses demonstrated that the predictive value of the VAT area for the extent of CAVI (mild: <25th percentile vs severe: >75th percentile) exceeded that of total or HMW adiponectin levels in both sexes. In conclusion, increased CAVI is associated with both amounts of VAT measured by computed tomography and serum HMW adiponectin levels in asymptomatic Japanese subjects. Receiver operating characteristic analysis indicates that the VAT area is a lot better predictor of arterial stiffness than adiponectin levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376553     DOI: 10.1016/j.metabol.2009.03.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Adiponectin expression and metabolic markers in obesity and Type 2 diabetes.

Authors:  S Kouidhi; S Jarboui; R Marrakchi; M-S Clerget Froidevaux; I Seugnet; H Abid; F Bchir; M Brahem; B Demeneix; H Guissouma; A Benammar Elgaaied
Journal:  J Endocrinol Invest       Date:  2010-07-22       Impact factor: 4.256

2.  Does prednisone use in pregnant women with rheumatoid arthritis induce insulin resistance in the offspring?

Authors:  Florentien D O de Steenwinkel; Radboud J E M Dolhain; Johanna M W Hazes; Anita C S Hokken-Koelega
Journal:  Clin Rheumatol       Date:  2022-08-30       Impact factor: 3.650

3.  Association of Metabolic Syndrome with the Cardioankle Vascular Index in Asymptomatic Korean Population.

Authors:  Su-Hyun Nam; Sung-Goo Kang; Yun-Ah Lee; Sang-Wook Song; Jun-Seung Rho
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

4.  Relationships of Obesity-Related Indices and Metabolic Syndrome with Subclinical Atherosclerosis in Middle-Aged Untreated Japanese Workers.

Authors:  Tomonori Sugiura; Yasuaki Dohi; Yasuyuki Takagi; Naofumi Yoshikane; Mitsuhisa Ito; Kenji Suzuki; Takashi Nagami; Mitsunori Iwase; Yoshihiro Seo; Nobuyuki Ohte
Journal:  J Atheroscler Thromb       Date:  2019-08-28       Impact factor: 4.928

5.  Lower ratio of high-molecular-weight adiponectin level to total may be associated with coronary high-risk plaque.

Authors:  Masao Moroi; Shamima Akter; Ryo Nakazato; Taeko Kunimasa; Hirofumi Masai; Tatsuhiko Furuhashi; Hiroshi Fukuda; Eiichi Koda; Kaoru Sugi; Subrina Jesmin
Journal:  BMC Res Notes       Date:  2013-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.